319 related articles for article (PubMed ID: 30094160)
1. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
Neuroimage Clin; 2018; 20():92-101. PubMed ID: 30094160
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):610-618. PubMed ID: 30826253
[TBL] [Abstract][Full Text] [Related]
3. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.
Lundin NB; Sepe-Forrest L; Gilbert JR; Carver FW; Furey ML; Zarate CA; Nugent AC
J Affect Disord; 2021 Jan; 279():239-249. PubMed ID: 33074143
[TBL] [Abstract][Full Text] [Related]
4. Modulation of amygdala reactivity following rapidly acting interventions for major depression.
Loureiro JRA; Leaver A; Vasavada M; Sahib AK; Kubicki A; Joshi S; Woods RP; Wade B; Congdon E; Espinoza R; Narr KL
Hum Brain Mapp; 2020 May; 41(7):1699-1710. PubMed ID: 32115848
[TBL] [Abstract][Full Text] [Related]
5. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
[TBL] [Abstract][Full Text] [Related]
7. 7T
Evans JW; Lally N; An L; Li N; Nugent AC; Banerjee D; Snider SL; Shen J; Roiser JP; Zarate CA
Neuropsychopharmacology; 2018 Aug; 43(9):1908-1914. PubMed ID: 29748628
[TBL] [Abstract][Full Text] [Related]
8. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
[TBL] [Abstract][Full Text] [Related]
9. Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration.
Evans JW; Szczepanik J; Brutsché N; Park LT; Nugent AC; Zarate CA
Biol Psychiatry; 2018 Oct; 84(8):582-590. PubMed ID: 29580569
[TBL] [Abstract][Full Text] [Related]
10. Attentional bias modification is associated with fMRI response toward negative stimuli in individuals with residual depression: a randomized controlled trial.
Hilland E; Landrø NI; Harmer CJ; Browning M; Maglanoc LA; Jonassen R
J Psychiatry Neurosci; 2020 Jan; 45(1):23-33. PubMed ID: 31397551
[TBL] [Abstract][Full Text] [Related]
11. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study.
Miskowiak KW; Kessing LV; Ott CV; Macoveanu J; Harmer CJ; Jørgensen A; Revsbech R; Jensen HM; Paulson OB; Siebner HR; Jørgensen MB
J Psychopharmacol; 2017 Sep; 31(9):1215-1224. PubMed ID: 28351201
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628
[TBL] [Abstract][Full Text] [Related]
13. Brain activation predicts treatment improvement in patients with major depressive disorder.
Samson AC; Meisenzahl E; Scheuerecker J; Rose E; Schoepf V; Wiesmann M; Frodl T
J Psychiatr Res; 2011 Sep; 45(9):1214-22. PubMed ID: 21477817
[TBL] [Abstract][Full Text] [Related]
14. Effects of ketamine on cognition-emotion interaction in the brain.
Scheidegger M; Henning A; Walter M; Boeker H; Weigand A; Seifritz E; Grimm S
Neuroimage; 2016 Jan; 124(Pt A):8-15. PubMed ID: 26348558
[TBL] [Abstract][Full Text] [Related]
15. Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression.
Gilbert JR; Galiano CS; Nugent AC; Zarate CA
Front Psychiatry; 2021; 12():673159. PubMed ID: 34220581
[TBL] [Abstract][Full Text] [Related]
16. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action.
Scheidegger M; Walter M; Lehmann M; Metzger C; Grimm S; Boeker H; Boesiger P; Henning A; Seifritz E
PLoS One; 2012; 7(9):e44799. PubMed ID: 23049758
[TBL] [Abstract][Full Text] [Related]
17. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects.
Moaddel R; Shardell M; Khadeer M; Lovett J; Kadriu B; Ravichandran S; Morris PJ; Yuan P; Thomas CJ; Gould TD; Ferrucci L; Zarate CA
Psychopharmacology (Berl); 2018 Oct; 235(10):3017-3030. PubMed ID: 30116859
[TBL] [Abstract][Full Text] [Related]
19. Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder.
Sterpenich V; Vidal S; Hofmeister J; Michalopoulos G; Bancila V; Warrot D; Dayer A; Desseilles M; Aubry JM; Kosel M; Schwartz S; Vutskits L
Anesthesiology; 2019 Jun; 130(6):923-935. PubMed ID: 31021848
[TBL] [Abstract][Full Text] [Related]
20. Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder.
Komulainen E; Heikkilä R; Nummenmaa L; Raij TT; Harmer CJ; Isometsä E; Ekelund J
J Affect Disord; 2018 Aug; 236():222-229. PubMed ID: 29747140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
